| Juliette Moore, MD | |
|
2055 Exchange St Ste 270, Astoria, OR 97103-3419 | |
| (503) 338-4670 | |
| (503) 338-4671 |
| Full Name | Juliette Moore |
|---|---|
| Gender | Female |
| Speciality | Surgery |
| Location | 2055 Exchange St Ste 270, Astoria, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700144615 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD179268 (Oregon) | Primary |
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
Andrew Witty, Chief Executive of GlaxoSmithKline, today announced a series of new initiatives targeted at further transforming the company's approach to diseases that disproportionately affect the world's poorest countries. His announcements build on commitments made in 2009 to work in partnership, expand access to medicines and encourage new research into neglected tropical diseases.
Americans for Responsible Heath Care is launching an independent television advertisement campaign in the Boston media market to educate Americans about the dangerous health care proposal being debated in Congress.
Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.
Scientists have identified a genetic signature that is remarkably effective at predicting the prognosis of an aggressive liver cancer in children.
A new drug discovered by scientists at Sanford Burnham Prebys Medical Discovery Institute may show promise for treating skin cancers that are resistant or unresponsive to today's leading therapies.
› Verified 4 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
Andrew Witty, Chief Executive of GlaxoSmithKline, today announced a series of new initiatives targeted at further transforming the company's approach to diseases that disproportionately affect the world's poorest countries. His announcements build on commitments made in 2009 to work in partnership, expand access to medicines and encourage new research into neglected tropical diseases.
Americans for Responsible Heath Care is launching an independent television advertisement campaign in the Boston media market to educate Americans about the dangerous health care proposal being debated in Congress.
Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.
Scientists have identified a genetic signature that is remarkably effective at predicting the prognosis of an aggressive liver cancer in children.
A new drug discovered by scientists at Sanford Burnham Prebys Medical Discovery Institute may show promise for treating skin cancers that are resistant or unresponsive to today's leading therapies.
› Verified 4 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578500492 PECOS PAC ID: 1557260106 Enrollment ID: O20040102000768 |
News Archive
Andrew Witty, Chief Executive of GlaxoSmithKline, today announced a series of new initiatives targeted at further transforming the company's approach to diseases that disproportionately affect the world's poorest countries. His announcements build on commitments made in 2009 to work in partnership, expand access to medicines and encourage new research into neglected tropical diseases.
Americans for Responsible Heath Care is launching an independent television advertisement campaign in the Boston media market to educate Americans about the dangerous health care proposal being debated in Congress.
Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.
Scientists have identified a genetic signature that is remarkably effective at predicting the prognosis of an aggressive liver cancer in children.
A new drug discovered by scientists at Sanford Burnham Prebys Medical Discovery Institute may show promise for treating skin cancers that are resistant or unresponsive to today's leading therapies.
› Verified 4 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366536963 PECOS PAC ID: 6103728753 Enrollment ID: O20040123000371 |
News Archive
Andrew Witty, Chief Executive of GlaxoSmithKline, today announced a series of new initiatives targeted at further transforming the company's approach to diseases that disproportionately affect the world's poorest countries. His announcements build on commitments made in 2009 to work in partnership, expand access to medicines and encourage new research into neglected tropical diseases.
Americans for Responsible Heath Care is launching an independent television advertisement campaign in the Boston media market to educate Americans about the dangerous health care proposal being debated in Congress.
Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.
Scientists have identified a genetic signature that is remarkably effective at predicting the prognosis of an aggressive liver cancer in children.
A new drug discovered by scientists at Sanford Burnham Prebys Medical Discovery Institute may show promise for treating skin cancers that are resistant or unresponsive to today's leading therapies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juliette Moore, MD 2111 Exchange St, Astoria, OR 97103-3329 Ph: () - | Juliette Moore, MD 2055 Exchange St Ste 270, Astoria, OR 97103-3419 Ph: (503) 338-4670 |
News Archive
Andrew Witty, Chief Executive of GlaxoSmithKline, today announced a series of new initiatives targeted at further transforming the company's approach to diseases that disproportionately affect the world's poorest countries. His announcements build on commitments made in 2009 to work in partnership, expand access to medicines and encourage new research into neglected tropical diseases.
Americans for Responsible Heath Care is launching an independent television advertisement campaign in the Boston media market to educate Americans about the dangerous health care proposal being debated in Congress.
Determining whether or not an individual has dementia and to what degree is a long and laborious process that can take an experienced professional such as a clinician about four to five hours to administer, interpret and score the test results. A leading neuroscientist at Florida Atlantic University has developed a way for a layperson to do this in three to five minutes with results that are comparable to the "gold standard" dementia tests used by clinicians today.
Scientists have identified a genetic signature that is remarkably effective at predicting the prognosis of an aggressive liver cancer in children.
A new drug discovered by scientists at Sanford Burnham Prebys Medical Discovery Institute may show promise for treating skin cancers that are resistant or unresponsive to today's leading therapies.
› Verified 4 days ago
Dr. Ali Dowlatdad, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2055 Exchange St, Suite 270, Astoria, OR 97103 Phone: 503-325-9597 Fax: 503-325-9639 | |
Truman M Sasaki, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2055 Exchange St, Suite 290, Astoria, OR 97103 Phone: 503-338-5353 Fax: 503-338-5252 | |
Dr. Eric Zimmermann, MD Surgery Medicare: Medicare Enrolled Practice Location: 2055 Exchange St Ste 270, Astoria, OR 97103 Phone: 503-338-4670 Fax: 503-338-4671 | |
Dr. Richard Arthur Crass, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2265 Exchange St, Astoria, OR 97103 Phone: 503-325-4321 Fax: 503-338-4018 | |
Dr. Brenda Joy Schmidt, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2111 Exchange St, Astoria, OR 97103 Phone: 503-325-4321 |